What is the primary reason apraclonidine is not used for long-term therapy?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

What is the primary reason apraclonidine is not used for long-term therapy?

Explanation:
Apraclonidine is used to lower IOP by stimulating alpha-2 receptors to reduce aqueous humor production, which makes it useful for short-term needs such as around procedures. The main reason it isn’t used for long-term therapy is that the eye commonly develops tachyphylaxis, so the IOP-lowering effect diminishes with continued use as receptors become desensitized. In addition, there is a relatively high rate of allergic conjunctivitis and conjunctival hyperemia with prolonged use, which often forces discontinuation. Because of these two factors—diminishing efficacy and ocular allergic reactions—apraclonidine isn’t suited for chronic management. The other issues mentioned, like systemic hypotension or lens interactions, are less central to its long-term use.

Apraclonidine is used to lower IOP by stimulating alpha-2 receptors to reduce aqueous humor production, which makes it useful for short-term needs such as around procedures. The main reason it isn’t used for long-term therapy is that the eye commonly develops tachyphylaxis, so the IOP-lowering effect diminishes with continued use as receptors become desensitized. In addition, there is a relatively high rate of allergic conjunctivitis and conjunctival hyperemia with prolonged use, which often forces discontinuation. Because of these two factors—diminishing efficacy and ocular allergic reactions—apraclonidine isn’t suited for chronic management. The other issues mentioned, like systemic hypotension or lens interactions, are less central to its long-term use.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy